To assess antiviral efficacy of anti-HCV ODNs, we used a well-established replicon system, I389/NS3-3’/LucUbiNeo-ET, stably expressed by human hepatoma Huh-7 clone 9b cells, as described [21] (Figure 1C). This evidence concerns the gene KRAS and hepatocellular carcinoma.